In liver cancer, allicin (40 μM ) inhibits Cholangiocarcinoma (CCA) cell proliferation and invasion through STAT3 signaling—STAT3 is a key transcription factor involved in proliferation [66]. This evidence concerns the gene STAT3 and cholangiocarcinoma.